Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 2
1980 1
1981 4
1982 5
1983 3
1985 2
1987 3
1988 2
1990 2
1991 6
1992 2
1993 1
1994 4
1995 1
1996 1
1997 4
1998 7
1999 9
2000 5
2001 8
2002 5
2003 12
2004 6
2005 6
2006 9
2007 7
2008 9
2009 11
2010 4
2011 6
2012 4
2013 10
2014 6
2015 6
2016 6
2017 4
2018 7
2019 7
2020 9
2021 10
2022 12
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Results by year

Filters applied: . Clear all
Page 1
The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy.
Lindberg K, Grozman V, Karlsson K, Lindberg S, Lax I, Wersäll P, Persson GF, Josipovic M, Khalil AA, Moeller DS, Nyman J, Drugge N, Bergström P, Olofsson J, Rogg LV, Ramberg C, Kristiansen C, Jeppesen SS, Nielsen TB, Lödén B, Rosenbrand HO, Engelholm S, Haraldsson A, Billiet C, Lewensohn R. Lindberg K, et al. Among authors: lewensohn r. J Thorac Oncol. 2021 Jul;16(7):1200-1210. doi: 10.1016/j.jtho.2021.03.019. Epub 2021 Apr 3. J Thorac Oncol. 2021. PMID: 33823286 Free article. Clinical Trial.
Metabolomics: moving to the clinic.
Nordström A, Lewensohn R. Nordström A, et al. Among authors: lewensohn r. J Neuroimmune Pharmacol. 2010 Mar;5(1):4-17. doi: 10.1007/s11481-009-9156-4. Epub 2009 Apr 28. J Neuroimmune Pharmacol. 2010. PMID: 19399626 Review.
18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial.
Cooke SA, de Ruysscher D, Reymen B, Lambrecht M, Fredberg Persson G, Faivre-Finn C, Dieleman EMT, Lewensohn R, van Diessen JNA, Sikorska K, Lalezari F, Vogel W, van Elmpt W, Damen EMF, Sonke JJ, Belderbos JSA. Cooke SA, et al. Among authors: lewensohn r. Radiother Oncol. 2023 Apr;181:109492. doi: 10.1016/j.radonc.2023.109492. Epub 2023 Jan 24. Radiother Oncol. 2023. PMID: 36706958 Clinical Trial.
The role of p53 in treatment responses of lung cancer.
Viktorsson K, De Petris L, Lewensohn R. Viktorsson K, et al. Among authors: lewensohn r. Biochem Biophys Res Commun. 2005 Jun 10;331(3):868-80. doi: 10.1016/j.bbrc.2005.03.192. Biochem Biophys Res Commun. 2005. PMID: 15865943 Review.
227 results